Within the spectrum of hematologic disorders, CD138 expression is highly sensitive and specific for plasmacytic differentiation and represents an excellent marker for routine evaluation of tissue samples for plasma cell disorders. This evidence concerns the gene SDC1 and hematologic disorder.